| May 12, 2014
| 11:38 AM
Drug maker Shire is buying San Diego-based Lumena Pharmaceuticals for more than $260 million, a deal that expands the company's pipeline of rare disease treatments.
The Irish company, producer of Adderall XR, plans to make a cash payment at the sale's...
| May 13, 2014
| 7:49 PM
The heated takeover fight over Allergan Inc., the maker of Botox, continued Tuesday with the Canadian pharmaceutical company Valeant vowing to increase its $46-billion offer this month.
Meanwhile, the Canadian firm's partner in the offer, activist...
| Apr 23, 2014
| 10:57 AM
Allergan Inc., the Irvine company that makes Botox, has adopted a "poison pill" defense that could make it more difficult for Canadian company Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman to force through a takeover bid....
| May 16, 2014
| 4:13 PM
At the 35th annual Scholarship Recognition Breakfast on Friday morning in Costa Mesa, the student recipients' stories were varied, their successes exceptional.
The banquet, hosted by the Costa Mesa Chamber of Commerce, took place at the Hilton Orange...
| May 19, 2014
| 2:45 PM
With no offense to Diane Dixon versus Michael Glenn, or Michael Toerge versus Scott Peotter, or even Tim Brown versus Roy Englebrecht, we may soon have a Newport Beach City Council race to watch.
On Wednesday, the "Draft Duffy" movement will start with a...
| Mar 27, 2014
| 6:34 PM
Ten Southern California surgery centers once affiliated with the defunct 1-800-GET-THIN advertising campaign are suing UnitedHealth Group Inc. to get reimbursed for hundreds of Lap-Band weight-loss procedures.
The lawsuit comes amid federal and state...
| Apr 22, 2014
| 7:33 PM
Canadian company Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman moved forward with their plans to acquire Botox maker Allergan Inc., offering shareholders about $46 billion and touching off what could be a contentious fight....
| Apr 21, 2014
| 8:41 PM
Activist investor Bill Ackman is partnering with a Canadian pharmaceutical company in an effort to buy Allergan Inc., the Irvine company that makes the popular wrinkle treatment Botox.
Ackman and Valeant Pharmaceuticals International Inc. have already...
| May 28, 2014
| 9:11 AM
Valeant on Wednesday boosted its cash-stock offer to buy Irvine company and Botox maker Allergan to $58.30 a share, raising the cash portion by $10, in a deal now worth about $50 billion.
The Canadian company offered its second, improved bid in the...
| May 27, 2014
| 6:33 PM
The billion-dollar takeover battle targeting Irvine-based Allergan is heading into high gear this week with both sides on the attack.
On Tuesday, Allergan Inc., the maker of Botox, launched a broadside against Canadian rival Valeant Pharmaceutics...
| May 28, 2014
| 5:37 PM
For weeks, Valeant Pharmaceuticals had promised a better offer for Botox maker Allergan, but its renewed cash-and-stock offer fell flat with investors and analysts.
After Irvine-based Allergan Inc. rejected a $46-billion offer earlier this month, the...